Literature DB >> 11435444

Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.

J S Rubin1, R M Day, D Breckenridge, N Atabey, W G Taylor, S J Stahl, P T Wingfield, J D Kaufman, R Schwall, D P Bottaro.   

Abstract

Hepatocyte growth factor (HGF) is a secreted, heparan sulfate (HS) glycosaminoglycan-binding protein that stimulates mitogenesis, motogenesis, and morphogenesis in a wide array of cellular targets, including hepatocytes and other epithelial cells, melanocytes, endothelial cells, and hematopoietic cells. NK1 is an alternative HGF isoform that consists of the N-terminal (N) and first kringle (K1) domains of full-length HGF and stimulates all major HGF biological activities. Within NK1, the N domain retains the HS binding properties of full-length HGF and mediates HS-stimulated ligand oligomerization but lacks significant mitogenic or motogenic activity. In contrast, K1 does not bind HS, but it stimulates receptor and mitogen-activated protein kinase activation, mitogenesis, and motogenesis, demonstrating that structurally distinct and dissociable domains of HGF are the primary mediators of HS binding and receptor activation. Despite the absence of HS-K1 binding, K1 mitogenic activity in HS-negative cells is strictly dependent on added soluble heparin, whereas K1-stimulated motility is not. We also found that, like the receptors for fibroblast growth factors, the HGF receptor c-Met binds tightly to HS. These data suggest that HS can facilitate HGF signaling through interaction with c-Met that is independent of HGF-HS interaction and that the recruitment of specific intracellular effectors that mediate distinct HGF responses such as mitogenesis and motility is regulated by HS-c-Met interaction at the cell surface.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435444     DOI: 10.1074/jbc.M105486200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.

Authors:  Ermanno Gherardi; Mark E Youles; Ricardo N Miguel; Tom L Blundell; Luisa Iamele; Julian Gough; Abhishek Bandyopadhyay; Guido Hartmann; P Jonathan G Butler
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-03       Impact factor: 11.205

2.  Regulating activation of transplanted cells controls tissue regeneration.

Authors:  Elliott Hill; Tanyarut Boontheekul; David J Mooney
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

3.  Incomplete target neutralization by the anti-cancer antibody rilotumumab.

Authors:  Sameer A Greenall; Timothy E Adams; Terrance G Johns
Journal:  MAbs       Date:  2016       Impact factor: 5.857

4.  The regulatory role of heparin on c-Met signaling in hepatocellular carcinoma cells.

Authors:  Evin İşcan; Aysim Güneş; Peyda Korhan; Yeliz Yılmaz; Esra Erdal; Neşe Atabey
Journal:  J Cell Commun Signal       Date:  2016-12-14       Impact factor: 5.782

5.  MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.

Authors:  Manuela Viola; Kathrin Brüggemann; Evgenia Karousou; Ilaria Caon; Elena Caravà; Davide Vigetti; Burkhard Greve; Christian Stock; Giancarlo De Luca; Alberto Passi; Martin Götte
Journal:  Glycoconj J       Date:  2016-10-15       Impact factor: 2.916

6.  SULF1 inhibits proliferation and invasion of esophageal squamous cell carcinoma cells by decreasing heparin-binding growth factor signaling.

Authors:  Chun-Tao Liu; Sheng-Tao Zhu; Peng Li; Yong-Jun Wang; Hao Zhang; Shu-Tian Zhang
Journal:  Dig Dis Sci       Date:  2012-10-05       Impact factor: 3.199

7.  High-level expression and characterization of bioactive human truncated variant of hepatocyte growth factor in Escherichia coli.

Authors:  Xiaohua Wang; Haifeng Liu; Zhongmin Zhang; Yang Liu; Yuting Li; Jinqiu Gui; Yanhui Chu
Journal:  World J Microbiol Biotechnol       Date:  2014-08-14       Impact factor: 3.312

8.  Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling.

Authors:  Fabiola Cecchi; Deborah Pajalunga; C Andrew Fowler; Aykut Uren; Daniel C Rabe; Benedetta Peruzzi; Nicholas J Macdonald; Davida K Blackman; Stephen J Stahl; R Andrew Byrd; Donald P Bottaro
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

9.  HIP/RPL29 antagonizes VEGF and FGF2 stimulated angiogenesis by interfering with HS-dependent responses.

Authors:  Sonia D'Souza; Weidong Yang; Dario Marchetti; Caroline Muir; Mary C Farach-Carson; Daniel D Carson
Journal:  J Cell Biochem       Date:  2008-12-01       Impact factor: 4.429

10.  Noncoding mutations of HGF are associated with nonsyndromic hearing loss, DFNB39.

Authors:  Julie M Schultz; Shaheen N Khan; Zubair M Ahmed; Saima Riazuddin; Ali M Waryah; Dhananjay Chhatre; Matthew F Starost; Barbara Ploplis; Stephanie Buckley; David Velásquez; Madhulika Kabra; Kwanghyuk Lee; Muhammad J Hassan; Ghazanfar Ali; Muhammad Ansar; Manju Ghosh; Edward R Wilcox; Wasim Ahmad; Glenn Merlino; Suzanne M Leal; Sheikh Riazuddin; Thomas B Friedman; Robert J Morell
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.